Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.

Item

http://www.wikidata.org/entity/Q53656617

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Anticoagulation after subcutan ...... nts treated with tenecteplase.

@en

Anticoagulation after subcutan ...... nts treated with tenecteplase.

@nl

type

Item

label

Anticoagulation after subcutan ...... nts treated with tenecteplase.

@en

Anticoagulation after subcutan ...... nts treated with tenecteplase.

@nl

prefLabel

Anticoagulation after subcutan ...... nts treated with tenecteplase.

@en

Anticoagulation after subcutan ...... nts treated with tenecteplase.

@nl

P1476

Anticoagulation after subcutan ...... nts treated with tenecteplase.

@en

P2093

Blair O'Neill

http://www.w3.org/2001/XMLSchema#string

Christopher E Buller

http://www.w3.org/2001/XMLSchema#string

Phillip Gordon

http://www.w3.org/2001/XMLSchema#string

P2860

Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment

A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study

Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis.

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.

Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin.

Pharmacokinetics of intravenous/subcutaneous Enoxaparin in patients with acute coronary syndrome undergoing percutaneous coronary interventions.

A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention.

P2888

s11239-012-0697-7

P304

126-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-012-0697-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert Welsh

Cynthia M. Westerhout

Paul W. Armstrong

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22362559

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation